Celloxess LLC

BioNanoTech is a pioneering company in Lawrence Township, NJ, that is revolutionizing the field of drug discovery and production. With their cutting-edge technology, they have developed the only technology capable of purifying proteins and antibodies across all size ranges, effectively turning waste into profit and accelerating the discovery of new cures. By capturing never-before-purified proteins with their innovative resins, BioNanoTech significantly reduces additional processing stages, providing ultra-high purity and unmatched capacity. Their groundbreaking technology eliminates the need to shelve drug and therapy candidates that are difficult or slow to purify, empowering companies to transform their existing protein antibody processes with greater quality and reduced lifetime costs.Generated from the website

Generation Biotech LLC is a cutting-edge biotechnology company based in Lawrence Township, NJ. They specialize in developing and providing innovative genomic research solutions, including their revolutionary Region-Specific Extraction (RSE) technology. RSE allows researchers and healthcare professionals to selectively process and analyze specific regions of interest in complex genomic samples, resulting in more efficient sequencing runs, faster turnaround time, and higher accuracy of results. With their expertise in long-read sequencing and target capture, Generation Biotech is at the forefront of advancing genomic research. Their RSE technology has been recognized for its significant contributions to the field, and their products have been extensively tested and manufactured in the US and Germany. Committed to research use only, Generation Biotech is dedicated to providing high-quality solutions that empower scientists and drive advancements in genomics.Generated from the website

Celsion Corporation, based in Lawrence Township, NJ, is a biotech company that specializes in developing innovative medicines that work in harmony with the body's immune system. Their breakthroughs are centered around harnessing the building blocks of life, such as immunology and DNA-based platforms, to address some of the most challenging medical conditions. With a team of experienced senior executives and key partnerships with renowned research institutions, Celsion is dedicated to solving the world's biggest healthcare problems, including vaccine-preventable diseases and cancer. Under the leadership of President and CEO Corinne Le Goff, who brings extensive experience in global healthcare and successful drug development, Celsion is committed to creating life-saving therapies. Their pipeline consists of products targeting a market worth $15 billion, with a focus on anti-cancer nucleic acid-based therapies and nucleic acid vaccines for infectious diseases and cancer. By prioritizing bold solutions and the opportunity for every individual to live a full life, Celsion is at the forefront of advancing medical science and improving patient outcomes.Generated from the website